Kalvista Pharmaceuticals Inc Revenue per Employee (KALV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Kalvista Pharmaceuticals Inc   (NASDAQ: KALV)
 

Kalvista Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Kalvista Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,244,022, below the company average number of $162,844.
Within the Healthcare sector Kalvista Pharmaceuticals Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Kalvista Pharmaceuticals Inc has 45 employees.


What is Sales per Employee Ratio?







KALV Revenue per Employee (Mar 31 2026)
I. Quarter
(Sep 30 2025)
III. Quarter
(Jul 31 2025)
I. Quarter
(Apr 30 2025)
IV. Quarter
(Jan 31 2025)
III. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 1,244,022 335,956 31,689 - -
KALV's Total Ranking # # # # #
Seq. Revenue Change 198.44 % 860.17 % - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 400,889 $ 162,844 $ 644
(Jan 31 2019)   (Sep 30 2016)



Financial Statements
Kalvista Pharmaceuticals Inc 's Revenue MRQ $ 41 Millions Visit KALV's Income Statement
Kalvista Pharmaceuticals Inc 's Revenues TTM $ 56 Millions Visit KALV's aggregate revenue growth
What are KALV's Sales? Visit KALV's Sales by Segment




Other Ratios
Kalvista Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KALV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KALV's Competitors
Revenue per Employee for KALV's Suppliers
Revenue per Employee for KALV's Customers

You may also want to know
KALV's Sales Growth Rates KALV's Pe Price to earnings ratio KALV's Receivables Turnover Ratio KALV's Stock Quote
KALV's Net Income Growth Rates KALV's Ps Price to Sales ratio KALV's Sales per Employee KALV's Asset Turnover Ratio
KALV's Net Margin KALV's Pb Price to Book ratio KALV's Financial Strength Ratios KALV's Dividend Payout Ratio
Date modified: 2026-09-26T07:07:31+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Exelixis Inc   2,071,047.08 $ 2,375.491  Million 1,147 
Kiniksa Pharmaceuticals International Plc  2,060,232.24 $ 754.045  Million 366 
Cormedix Inc   2,040,572.14 $ 389.749  Million 191 
Biocryst Pharmaceuticals Inc   2,036,128.74 $ 885.716  Million 435 
Eton Pharmaceuticals Inc   1,968,500.00 $ 86.614  Million 44 
Assertio Holdings inc   1,927,509.43 $ 102.158  Million 53 
Siga Technologies Inc  1,913,809.53 $ 93.777  Million 49 
Prestige Consumer Healthcare Inc   1,909,785.96 $ 1,088.578  Million 570 
Zevra Therapeutics Inc   1,886,442.62 $ 115.073  Million 61 
Incyte Corporation  1,885,028.13 $ 5,361.020  Million 2,844 
Privia Health Group Inc   1,832,456.77 $ 2,246.592  Million 1,226 
Tg Therapeutics Inc   1,755,260.65 $ 700.349  Million 399 
Gilead Sciences Inc   1,749,176.47 $ 29,736.000  Million 17,000 
Collegium Pharmaceutical Inc   1,747,635.93 $ 739.250  Million 423 
Rigel Pharmaceuticals Inc  1,722,798.85 $ 299.767  Million 174 
Alnylam Pharmaceuticals Inc   1,714,769.20 $ 4,286.923  Million 2,500 
Atara Biotherapeutics Inc   1,681,428.57 $ 23.540  Million 14 
Xenetic Biosciences Inc   1,595,036.50 $ 3.190  Million 2 
Soleno Therapeutics Inc  1,565,978.02 $ 285.008  Million 182 
Neurocrine Biosciences Inc   1,551,200.00 $ 3,102.400  Million 2,000 
Jazz Pharmaceuticals Plc  1,535,863.32 $ 4,438.645  Million 2,890 
Mirum Pharmaceuticals Inc   1,531,206.99 $ 569.609  Million 372 
Agenus Inc  1,529,209.88 $ 123.866  Million 81 
Progyny Inc   1,510,233.64 $ 1,292.760  Million 856 
Apellis Pharmaceuticals Inc   1,495,642.76 $ 1,105.280  Million 739 
Bristol myers Squibb Company  1,491,753.85 $ 48,482.000  Million 32,500 
Fennec Pharmaceuticals Inc   1,457,114.29 $ 50.999  Million 35 
Tarsus Pharmaceuticals Inc   1,446,159.46 $ 535.079  Million 370 
Eli Lilly And Company  1,444,990.00 $ 72,249.500  Million 50,000 
Esperion Therapeutics Inc   1,422,598.64 $ 418.244  Million 294 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.